MS

Manish Singh

Active Director Director DIN 10182270
DIN 10182270 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Manish Singh

Data last updated:

Manish Singh is a Director at Nkb Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Nkb Pharmaceuticals Private Limited reported revenue of ₹25,753 (FY 2025).

DIN 10182270
Primary Designation Director
Industry Pharma
First Appointment 30 May 2023
Oldest Company Age 3 yrs
Largest company Nkb Pharmaceuticals Private Limited · ₹25,753 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nkb Pharmaceuticals Private Limited U47721UP2023PTC183002
Director30 May 20232023₹25,753 (FY 2025)Active

Board colleagues of Manish Singh

Directorship timeline

Open interactive timeline →
Nkb Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manish Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Singh

Manish Singh currently holds 1 directorship: Nkb Pharmaceuticals Private Limited (Director, since 30 May 2023, revenue ₹25,753 (FY 2025)).

Manish Singh was first appointed on 30 May 2023 as Director at Nkb Pharmaceuticals Private Limited.

The current boards of Manish Singh's companies include Needhi Singh (Nkb Pharmaceuticals Private Limited), Sudha Shrivastav (Nkb Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available